1.85

1.09% 0.02

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $1.85, with a volume of 626.68K. It is up +1.09% in the last 24 hours and down -29.92% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Previous Close:

$1.83

Open:

$1.83

24h Volume:

626.68K

Relative Volume:

0.79

Market Cap:

$117.88M

Revenue:

$198.53M

Net Income/Loss:

$-63.68M

P/E Ratio:

-1.8098

EPS:

-1.0222

Net Cash Flow:

$-41.50M

1W Performance:

-8.42%

1M Performance:

-29.92%

6M Performance:

-73.72%

1Y Performance:

-81.92%

1-Day Range:

$1.82

$1.9288

1-Week Range:

$1.81

$2.045

52-Week Range:

$1.81

$10.30

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1110)

Industry

Medical Devices (139)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

477

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	1.85	116.60M	198.53M	-63.68M	-41.50M	-1.0222
ABT Abbott Laboratories	113.29	195.21B	44.33B	6.48B	6.92B	3.7033
SYK Stryker Corp	377.32	141.28B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	98.49	123.60B	35.48B	4.64B	5.41B	3.5856
BSX Boston Scientific Corp	76.28	113.14B	20.08B	2.89B	3.82B	1.9391
EW Edwards Lifesciences Corp	78.98	45.52B	6.07B	1.06B	799.60M	1.8527

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy
Dec-31-24	Initiated	Lake Street	Buy
Dec-17-24	Resumed	JP Morgan	Neutral
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

02:37 AM

Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday - Defense World

02:37 AM

Feb 18, 2026

What Catalysts Are Shifting The Narrative For Treace Medical Concepts (TMCI)? - Yahoo Finance

Feb 18, 2026

Feb 17, 2026

Retail Trends: How much upside does Treace Medical Concepts Inc have2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn

Feb 17, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Reduce" by Brokerages - MarketBeat

Feb 17, 2026

Feb 16, 2026